Report Cover

Global Deuterated Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028


The Deuterated Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Deuterated Drugs market size will reach USD  million in 2028, growing at a CAGR of  % over the analysis period.
Global key companies of Deuterated Drugs include Teva, Suzhou Zelgen Biopharmaceuticals, Concert Pharmaceuticals, Vertex Pharmaceuticals, and Hinova Pharma, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Deuterated Drugs market is split by Type and by Application. For the period 2012-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Austedo
    Zepsun
    Others
Market segment by Application, can be divided into
    Huntington'S Disease (HD)
    Tardive Dyskinesia (TD)
    Cancer
    Others
Market segment by players, this report covers
    Teva
    Suzhou Zelgen Biopharmaceuticals
    Concert Pharmaceuticals
    Vertex Pharmaceuticals
    Hinova Pharma
    Otsuka Pharmaceutical (Avanir)
    Poxel SA (DeuteRx)
Market segment by regions, regional analysis covers
    North America
    Europe
    Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
    South America
    Middle East & Africa
The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe Deuterated Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Deuterated Drugs, with recent developments and future plans
Chapter 3, the Deuterated Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and Deuterated Drugs market forecast, by regions, with revenue, from 2022 to 2028.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2022 to 2028.
Chapter 7 and 8, to describe Deuterated Drugs research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 Product Overview and Scope of Deuterated Drugs
    1.2 Classification of Deuterated Drugs by Type
        1.2.1 Overview: Global Deuterated Drugs Market Size by Type: 2022 Versus 2028
        1.2.2 Global Deuterated Drugs Revenue Market Share by Type in 2028
        1.2.3 Austedo
        1.2.4 Zepsun
        1.2.5 Others
    1.3 Global Deuterated Drugs Market by Application
        1.3.1 Overview: Global Deuterated Drugs Market Size by Application: 2022 Versus 2028
        1.3.2 Huntington'S Disease (HD)
        1.3.3 Tardive Dyskinesia (TD)
        1.3.4 Cancer
        1.3.5 Others
    1.4 Global Deuterated Drugs Market Size & Forecast
    1.5 Market Drivers, Restraints and Trends
        1.5.1 Deuterated Drugs Market Drivers
        1.5.2 Deuterated Drugs Market Restraints
        1.5.3 Deuterated Drugs Trends Analysis
2 Company Profiles
    2.1 Teva
        2.1.1 Teva Details
        2.1.2 Teva Major Business
        2.1.3 Teva Deuterated Drugs Product and Solutions
        2.1.4 Teva Recent Developments and Future Plans
    2.2 Suzhou Zelgen Biopharmaceuticals
        2.2.1 Suzhou Zelgen Biopharmaceuticals Details
        2.2.2 Suzhou Zelgen Biopharmaceuticals Major Business
        2.2.3 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Product and Solutions
        2.2.4 Suzhou Zelgen Biopharmaceuticals Recent Developments and Future Plans
    2.3 Concert Pharmaceuticals
        2.3.1 Concert Pharmaceuticals Details
        2.3.2 Concert Pharmaceuticals Major Business
        2.3.3 Concert Pharmaceuticals Deuterated Drugs Product and Solutions
        2.3.4 Concert Pharmaceuticals Recent Developments and Future Plans
    2.4 Vertex Pharmaceuticals
        2.4.1 Vertex Pharmaceuticals Details
        2.4.2 Vertex Pharmaceuticals Major Business
        2.4.3 Vertex Pharmaceuticals Deuterated Drugs Product and Solutions
        2.4.4 Vertex Pharmaceuticals Recent Developments and Future Plans
    2.5 Hinova Pharma
        2.5.1 Hinova Pharma Details
        2.5.2 Hinova Pharma Major Business
        2.5.3 Hinova Pharma Deuterated Drugs Product and Solutions
        2.5.4 Hinova Pharma Recent Developments and Future Plans
    2.6 Otsuka Pharmaceutical (Avanir)
        2.6.1 Otsuka Pharmaceutical (Avanir) Details
        2.6.2 Otsuka Pharmaceutical (Avanir) Major Business
        2.6.3 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Product and Solutions
        2.6.4 Otsuka Pharmaceutical (Avanir) Recent Developments and Future Plans
    2.7 Poxel SA (DeuteRx)
        2.7.1 Poxel SA (DeuteRx) Details
        2.7.2 Poxel SA (DeuteRx) Major Business
        2.7.3 Poxel SA (DeuteRx) Deuterated Drugs Product and Solutions
        2.7.4 Poxel SA (DeuteRx) Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Deuterated Drugs Revenue and Share by Players (2022 & 2028)
    3.2 Deuterated Drugs Players Head Office, Products and Services Provided
    3.3 Deuterated Drugs Mergers & Acquisitions
    3.4 Deuterated Drugs New Entrants and Expansion Plans
4 Global Deuterated Drugs Forecast by Region
    4.1 Global Deuterated Drugs Market Size by Region: 2022 VS 2028
    4.2 Global Deuterated Drugs Market Size by Region, (2022-2028)
    4.3 North America
        4.3.1 Key Companies of Deuterated Drugs in North America
        4.3.2 Current Situation and Forecast of Deuterated Drugs in North America
        4.3.3 North America Deuterated Drugs Market Size and Prospect (2022-2028)
    4.4 Europe
        4.4.1 Key Companies of Deuterated Drugs in Europe
        4.4.2 Current Situation and Forecast of Deuterated Drugs in Europe
        4.4.3 Europe Deuterated Drugs Market Size and Prospect (2022-2028)
    4.5 Asia-Pacific
        4.5.1 Key Companies of Deuterated Drugs in Asia-Pacific
        4.5.2 Current Situation and Forecast of Deuterated Drugs in Asia-Pacific
        4.5.3 Asia-Pacific Deuterated Drugs Market Size and Prospect (2022-2028)
    4.6 South America
        4.6.1 Key Companies of Deuterated Drugs in South America
        4.6.2 Current Situation and Forecast of Deuterated Drugs in South America
        4.6.3 South America Deuterated Drugs Market Size and Prospect (2022-2028)
    4.7 Middle East & Africa
        4.7.1 Key Companies of Deuterated Drugs in Middle East & Africa
        4.7.2 Current Situation and Forecast of Deuterated Drugs in Middle East & Africa
        4.7.3 Middle East & Africa Deuterated Drugs Market Size and Prospect (2022-2028)
5 Market Size Segment by Type
    5.1 Global Deuterated Drugs Market Forecast by Type (2022-2028)
    5.2 Global Deuterated Drugs Market Share Forecast by Type (2022-2028)
6 Market Size Segment by Application
    6.1 Global Deuterated Drugs Market Forecast by Application (2022-2028)
    6.2 Global Deuterated Drugs Market Share Forecast by Application (2022-2028)
7 Research Findings and Conclusion
8 Appendix
    8.1 Methodology
    8.2 Research Process and Data Source
    8.3 Disclaimer

List of Tables Table 1. Global Deuterated Drugs Revenue by Type, (USD Million), 2022 VS 2028 Table 2. Global Deuterated Drugs Revenue by Application, (USD Million), 2022 VS 2028 Table 3. Teva Corporate Information, Head Office, and Major Competitors Table 4. Teva Major Business Table 5. Teva Deuterated Drugs Product and Solutions Table 6. Suzhou Zelgen Biopharmaceuticals Corporate Information, Head Office, and Major Competitors Table 7. Suzhou Zelgen Biopharmaceuticals Major Business Table 8. Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Product and Solutions Table 9. Concert Pharmaceuticals Corporate Information, Head Office, and Major Competitors Table 10. Concert Pharmaceuticals Major Business Table 11. Concert Pharmaceuticals Deuterated Drugs Product and Solutions Table 12. Vertex Pharmaceuticals Corporate Information, Head Office, and Major Competitors Table 13. Vertex Pharmaceuticals Major Business Table 14. Vertex Pharmaceuticals Deuterated Drugs Product and Solutions Table 15. Hinova Pharma Corporate Information, Head Office, and Major Competitors Table 16. Hinova Pharma Major Business Table 17. Hinova Pharma Deuterated Drugs Product and Solutions Table 18. Otsuka Pharmaceutical (Avanir) Corporate Information, Head Office, and Major Competitors Table 19. Otsuka Pharmaceutical (Avanir) Major Business Table 20. Otsuka Pharmaceutical (Avanir) Deuterated Drugs Product and Solutions Table 21. Poxel SA (DeuteRx) Corporate Information, Head Office, and Major Competitors Table 22. Poxel SA (DeuteRx) Major Business Table 23. Poxel SA (DeuteRx) Deuterated Drugs Product and Solutions Table 24. Global Deuterated Drugs Revenue (USD Million) by Players (2022 & 2028) Table 25. Global Deuterated Drugs Revenue Share by Players (2022 & 2028) Table 26. Deuterated Drugs Players Head Office, Products and Services Provided Table 27. Deuterated Drugs Mergers & Acquisitions in the Past Five Years Table 28. Deuterated Drugs New Entrants and Expansion Plans Table 29. Global Market Deuterated Drugs Revenue (USD Million) Comparison by Region (2022 VS 2028) Table 30. Global Deuterated Drugs Revenue Market Share by Region (2022-2028) Table 31. Key Companies of Deuterated Drugs in North America Table 32. Current Situation and Forecast of Deuterated Drugs in North America Table 33. Key Companies of Deuterated Drugs in Europe Table 34. Current Situation and Forecast of Deuterated Drugs in Europe Table 35. Key Companies of Deuterated Drugs in Asia-Pacific Table 36. Current Situation and Forecast of Deuterated Drugs in Asia-Pacific Table 37. Key Companies of Deuterated Drugs in China Table 38. Key Companies of Deuterated Drugs in Japan Table 39. Key Companies of Deuterated Drugs in South Korea Table 40. Key Companies of Deuterated Drugs in South America Table 41. Current Situation and Forecast of Deuterated Drugs in South America Table 42. Key Companies of Deuterated Drugs in Middle East & Africa Table 43. Current Situation and Forecast of Deuterated Drugs in Middle East & Africa Table 44. Global Deuterated Drugs Revenue Forecast by Type (2022-2028) Table 45. Global Deuterated Drugs Revenue Forecast by Application (2022-2028) List of Figures Figure 1. Deuterated Drugs Picture Figure 2. Global Deuterated Drugs Revenue Market Share by Type in 2028 Figure 3. Austedo Figure 4. Zepsun Figure 5. Others Figure 6. Deuterated Drugs Revenue Market Share by Application in 2028 Figure 7. Huntington'S Disease (HD) Picture Figure 8. Tardive Dyskinesia (TD) Picture Figure 9. Cancer Picture Figure 10. Others Picture Figure 11. Global Deuterated Drugs Market Size, (USD Million): 2022 VS 2028 Figure 12. Global Deuterated Drugs Revenue and Forecast (2022-2028) & (USD Million) Figure 13. Deuterated Drugs Market Drivers Figure 14. Deuterated Drugs Market Restraints Figure 15. Deuterated Drugs Market Trends Figure 16. Teva Recent Developments and Future Plans Figure 17. Suzhou Zelgen Biopharmaceuticals Recent Developments and Future Plans Figure 18. Concert Pharmaceuticals Recent Developments and Future Plans Figure 19. Vertex Pharmaceuticals Recent Developments and Future Plans Figure 20. Hinova Pharma Recent Developments and Future Plans Figure 21. Otsuka Pharmaceutical (Avanir) Recent Developments and Future Plans Figure 22. Poxel SA (DeuteRx) Recent Developments and Future Plans Figure 23. Global Deuterated Drugs Revenue Market Share by Region (2022-2028) Figure 24. Global Deuterated Drugs Revenue Market Share by Region in 2028 Figure 25. North America Deuterated Drugs Revenue (USD Million) and Growth Rate (2022-2028) Figure 26. Europe Deuterated Drugs Revenue (USD Million) and Growth Rate (2022-2028) Figure 27. Asia-Pacific Deuterated Drugs Revenue (USD Million) and Growth Rate (2022-2028) Figure 28. South America Deuterated Drugs Revenue (USD Million) and Growth Rate (2022-2028) Figure 29. Middle East & Africa Deuterated Drugs Revenue (USD Million) and Growth Rate (2022-2028) Figure 30. Global Deuterated Drugs Market Share Forecast by Type (2022-2028) Figure 31. Global Deuterated Drugs Market Share Forecast by Application (2022-2028) Figure 32. Methodology Figure 33. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us